norfloxacin has been researched along with thymol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Gozalbes, R; Pineda-Lucena, A | 1 |
| Kim, JH; Shin, S | 1 |
| Coutinho, HDM; da Cunha, FAB; de Freitas, TS; de Jesus, SSP; de Menezes, IRA; de Morais Oliveira-Tintino, CD; de Sousa Silveira, Z; Dos Santos Barbosa, CR; Dos Santos, JFS; Júnior, JPS; Lopes, TP; Pereira, RLS; Scherf, JR; Tintino, SR | 1 |
3 other study(ies) available for norfloxacin and thymol
| Article | Year |
|---|---|
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
In vitro inhibitory activities of essential oils from two Korean thymus species against antibiotic-resistant pathogens.
Topics: Anti-Bacterial Agents; Bacteria; Cymenes; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Synergism; Korea; Microbial Sensitivity Tests; Monoterpenes; Norfloxacin; Plant Oils; Salmonella typhimurium; Staphylococcus aureus; Streptococcus pneumoniae; Thymol; Thymus Plant | 2005 |
Effect of Carvacrol and Thymol on NorA efflux pump inhibition in multidrug-resistant (MDR) Staphylococcus aureus strains.
Topics: Cymenes; Multidrug Resistance-Associated Proteins; Norfloxacin; Staphylococcus aureus; Thymol | 2021 |